Samuel Chao
Distinguished in Oligodendroglioma

Dr. Samuel Chao

Radiation Oncology
Cleveland Clinic
Cleveland Clinic Main Campus
10201 Carnegie Avenue, 
Cleveland, OH 
On Staff At
Offers Telehealth
29 Years of Experience
Distinguished in Oligodendroglioma
Cleveland Clinic
Cleveland Clinic Main Campus
10201 Carnegie Avenue, 
Cleveland, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Samuel Chao is a Radiation Oncologist in Cleveland, Ohio. Dr. Chao has been practicing medicine for over 29 years and is rated as a Distinguished provider by MediFind in the treatment of Oligodendroglioma. His top areas of expertise are Brain Tumor, Glioma, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery.

His clinical research consists of co-authoring 216 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Oligodendroglioma.

Graduate Institution
Stanford University, 1997.0
Residency
Cleveland Clinic
Specialties
Radiation Oncology
Licenses
Radiology in OH
Board Certifications
American Board Of Radiology, 2007
Hospital Affiliations
Multicare Auburn Medical Center
Cleveland Clinic
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Cleveland Clinic Main Campus
10201 Carnegie Avenue, Cleveland, OH 44106
Call: 866-223-8100
Other Locations
Wooster Milltown Specialty and Surgery Center
721 East Milltown Road, Wooster, OH 44691
Call: 330-287-4500

Additional Areas of Focus

Dr. Chao has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: October 20, 2025
Intervention Type: Procedure, Biological, Radiation
Study Drugs: Atezolizumab, Tocilizumab
Study Phase: Phase 2
Dose Escalation for Larger Brain Metastases: Phase I/II Study
Dose Escalation for Larger Brain Metastases: Phase I/II Study
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Procedure, Radiation
Study Phase: Phase 1
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: August 02, 2024
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Enrollment Status: Completed
Publish Date: May 25, 2022
Intervention Type: Radiation
Study Phase: Phase 1
Phase II Trial Of Optune® Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma
Phase II Trial Of Optune® Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma
Enrollment Status: Terminated
Publish Date: June 02, 2021
Intervention Type: Device, Drug
Study Phase: Phase 2
A Prospective Pilot to Evaluate the Diagnostic Assessment of 18F-Fluciclovine Positron Emission Tomography to Distinguish Tumor Progression From Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases
A Prospective Pilot to Evaluate the Diagnostic Assessment of 18F-Fluciclovine Positron Emission Tomography to Distinguish Tumor Progression From Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases
Enrollment Status: Completed
Publish Date: May 05, 2021
Intervention Type: Device, Drug
Study Phase: Early Phase 1
View 7 Less Clinical Trials

216 Total Publications

ACR-ARS Practice Parameter for the Performance of Stereotactic Body Radiation Therapy.
ACR-ARS Practice Parameter for the Performance of Stereotactic Body Radiation Therapy.
Journal: American journal of clinical oncology
Published: June 23, 2025
View All 216 Publications
Similar Doctors
Distinguished in Oligodendroglioma
Dr. John H. Suh
Radiation Oncology
Distinguished in Oligodendroglioma
Dr. John H. Suh
Radiation Oncology

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (0.3 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Suh is a Radiation Oncologist in Cleveland, Ohio. Dr. Suh is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. His top areas of expertise are Brain Tumor, Glioma, Glioblastoma, Astrocytoma, and Gamma Knife Radiosurgery.

Advanced in Oligodendroglioma
Dr. Roger Ove
Radiation Oncology
Advanced in Oligodendroglioma
Dr. Roger Ove
Radiation Oncology

The Metrohealth System

2500 Metrohealth Dr, 
Cleveland, OH 
 (5.1 miles away)
216-778-7800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Roger Ove is a Radiation Oncologist in Cleveland, Ohio. Dr. Ove is rated as a Distinguished provider by MediFind in the treatment of Oligodendroglioma. His top areas of expertise are Prostate Cancer, Oligodendroglioma, Astrocytoma, and Familial Prostate Cancer. Dr. Ove is currently accepting new patients.

Praveen Pendyala
Advanced in Oligodendroglioma
Dr. Praveen Pendyala
Radiation Oncology
Advanced in Oligodendroglioma
Dr. Praveen Pendyala
Radiation Oncology

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
 (0.1 miles away)
866-223-8100
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Praveen Pendyala is a Radiation Oncologist in Cleveland, Ohio. Dr. Pendyala has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Familial Prostate Cancer, Prostate Cancer, and Astrocytoma.

VIEW MORE OLIGODENDROGLIOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chao's expertise for a condition
ConditionClose
  • Elite
  • Astrocytoma
    Dr. Chao is
    Elite
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Brain Tumor
    Dr. Chao is
    Elite
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Gamma Knife Radiosurgery
    Dr. Chao is
    Elite
    . Learn about Gamma Knife Radiosurgery.
    See more Gamma Knife Radiosurgery experts
  • Glioblastoma
    Dr. Chao is
    Elite
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Glioma
    Dr. Chao is
    Elite
    . Learn about Glioma.
    See more Glioma experts
  • Meningioma
    Dr. Chao is
    Elite
    . Learn about Meningioma.
    See more Meningioma experts
View All 7 Elite Conditions
  • Distinguished
  • Acoustic Neuroma
    Dr. Chao is
    Distinguished
    . Learn about Acoustic Neuroma.
    See more Acoustic Neuroma experts
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Chao is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Bone Tumor
    Dr. Chao is
    Distinguished
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Choroid Plexus Carcinoma
    Dr. Chao is
    Distinguished
    . Learn about Choroid Plexus Carcinoma.
    See more Choroid Plexus Carcinoma experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Chao is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Ependymoma
    Dr. Chao is
    Distinguished
    . Learn about Ependymoma.
    See more Ependymoma experts
View All 17 Distinguished Conditions
  • Advanced
  • Adult Soft Tissue Sarcoma
    Dr. Chao is
    Advanced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Arteriovenous Malformation
    Dr. Chao is
    Advanced
    . Learn about Arteriovenous Malformation.
    See more Arteriovenous Malformation experts
  • Brain Stem Cancer
    Dr. Chao is
    Advanced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
  • Chordoma
    Dr. Chao is
    Advanced
    . Learn about Chordoma.
    See more Chordoma experts
  • Choroid Plexus Papilloma
    Dr. Chao is
    Advanced
    . Learn about Choroid Plexus Papilloma.
    See more Choroid Plexus Papilloma experts
  • Craniopharyngioma
    Dr. Chao is
    Advanced
    . Learn about Craniopharyngioma.
    See more Craniopharyngioma experts
View All 28 Advanced Conditions
  • Experienced
  • Acinic Cell Carcinoma of Salivary Glands
    Dr. Chao is
    Experienced
    . Learn about Acinic Cell Carcinoma of Salivary Glands.
    See more Acinic Cell Carcinoma of Salivary Glands experts
  • Adenoid Cystic Carcinoma
    Dr. Chao is
    Experienced
    . Learn about Adenoid Cystic Carcinoma.
    See more Adenoid Cystic Carcinoma experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Chao is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Alveolar Soft Part Sarcoma
    Dr. Chao is
    Experienced
    . Learn about Alveolar Soft Part Sarcoma.
    See more Alveolar Soft Part Sarcoma experts
  • Anal Cancer
    Dr. Chao is
    Experienced
    . Learn about Anal Cancer.
    See more Anal Cancer experts
  • Anaplastic Thyroid Cancer
    Dr. Chao is
    Experienced
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
View All 67 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.